Efektivitas Penggunaan Ringer Laktat Vs Ringer Asetat terhadap Durasi Rawat Inap Pasien Demam Berdarah Dengue

Authors

  • Erwin Ari Pratiwi Universitas Muhammadiyah Kudus
  • Eko Retnowati Universitas Muhammadiyah Kudus
  • Intan Adevia Rosnarita Universitas Muhammadiyah Kudus

DOI:

https://doi.org/10.55606/jikki.v5i1.7462

Keywords:

Dengue Hemorrhagic Fever, Fluid Therapy, length of stay, Ringer Acetate, Ringer Lactate

Abstract

Dengue hemorrhagic fever (DHF) is an endemic disease with high prevalence in Indonesia, particularly during the rainy season, when incidence rates significantly increase. One of the main treatments is supportive therapy through intravenous fluid administration to prevent shock and aid recovery. Ringer’s lactate and Ringer’s acetate are commonly used crystalloid fluids that differ in electrolyte composition and metabolic pathways in the body. This study aimed to compare the effectiveness of Ringer’s lactate and Ringer’s acetate in relation to the length of hospital stay among DHF patients. This research employed a retrospective analytic observational design, using data from medical records of 154 inpatients at RSUD dr. R. Soetrasno Rembang in 2024. Data analysis included normality testing and independent t-tests. The average length of hospitalization in the Ringer’s lactate group was 4.35 ± 1.121 days, while in the Ringer’s acetate group it was 4.06 ± 1.185 days. Although there was a difference in mean values, statistical analysis showed no significant difference between the two groups (p = 0.131). No significant differences were also found in laboratory parameters (platelets, leukocytes, hemoglobin, hematocrit) or body temperature. Based on these findings, it can be concluded that both types of fluids are equally effective as supportive therapy for DHF patients. Fluid selection may be adjusted according to the patient’s clinical condition, availability, and cost considerations.

 

 

References

Agustina, W. D., Yudhaswara, N. A., & Nurdin, T. W. (2023). Analisis darah (Hemoglobin, Hematokrit dan Trombosit) pada pasien anak Demam Berdarah Dengue. JKP (Jurnal Kesehatan Primer), 8.

Alda, A. S., Madjid, D. A., Eva, F., Darma, S., & Maulani, D. (2024). Karakteristik kejadian Demam Berdarah Dengue pada anak. Fakumi Medical Journal: Jurnal Mahasiswa Kedokteran, 4(7), 539–547. https://doi.org/10.33096/fmj.v4i7.466

Aspuria-Ang, M. A., Astih, E. J., Palon, A. K. M., & Torres, M. J. S. (2018). A comparative study of acetated isotonic electrolyte solution, normal saline solution, and lactated ringer’s solution in the initial fluid resuscitation of children with severe dengue. Herdin Record, 14(1), 43–60.

Assegaf, S., Puspitasari, D., & Ginting, A. P. (2021). Perbedaan dan pola jumlah trombosit, leukosit, serta hematokrit pada penderita Dengue Fever dan Dengue Hemorrhagic Fever. Sari Pediatri, 23(1), 51–56. https://doi.org/10.14238/sp23.1.2021.51-6

Ayu Islammia, D. P., Rumana, N. A., Indawati, L., & Dewi, D. R. (2022). Karakteristik pasien Demam Berdarah Dengue rawat inap di Rumah Sakit Umum UKI tahun 2020. SEHATMAS: Jurnal Ilmiah Kesehatan Masyarakat, 1(1), 60–70. https://doi.org/10.55123/sehatmas.v1i1.37

Badan Kebijakan Pembangunan Kesehatan. (2023). Survei Kesehatan Indonesia (SKI) (pp. 201–202). Kementerian Kesehatan Republik Indonesia. https://www.badankebijakan.kemkes.go.id/Ski-2023-Dalam-Angka/

Baihui Xu, Tewari, P., Thein, T. L., Sin, L. Y., Lye, D. C. B., Chia, P. Y., & Lim, J. T. (2024). Intravenous fluid therapy in hospitalized adult dengue patients without shock. Journal of Medical Virology, 96. https://doi.org/10.1002/jmv.29726

Borré-Naranjo, D., Cárdenas-Bolívar, Y., Manzur-Barbur, M., Toro, E., Buendía, E., Martínez, M. C., ... & Dueñas-Castell, C. (2022). Fluid management in dengue critical phase. International Archives of Medical Microbiology, 4(1). https://doi.org/10.23937/2643-4008/1710015

Boyd, C. J., Brainard, B. M., & Smart, L. (2021). Intravenous fluid administration and the coagulation system. Frontiers in Veterinary Science, 8, 662504. https://doi.org/10.3389/fvets.2021.662504

Bur, R., Suwarto, S., Pohan, H. T., Prihartono, J., Harahap, A. R., Dewi, B. E., ... & Yusuf, H. (2024). Early intervention of 5% albumin vs. ringer’s lactate in adult dengue hemorrhagic fever. Tropical Diseases, Travel Medicine and Vaccines, 10(1), 20. https://doi.org/10.1186/s40794-024-00230-3

Cici Farhana Ambarwanty Mohtar, Setyarini, U. P., & Widyayanti, O. A. (2024). Hubungan antara pemeriksaan antibodi IgG dengan SGOT-SGPT pada pasien DBD. Protein: Jurnal Ilmu Keperawatan dan Kebidanan, 2(3), 168–176. https://doi.org/10.61132/protein.v2i3.581

Eko Retnowati, Sholihah, S., Hasanatin, S., & Fitria, N. E. L. (2023). Rasionalitas penggunaan parasetamol pada anak 1–12 tahun DBD. Prosiding University Research Colloquium, 1571–1576.

Hahn, R. G. (2017). Influences of RBC and platelet counts on crystalloid fluid. Medicina, 53(4), 233–241. https://doi.org/10.1016/j.medici.2017.07.005

Helvy Yuliana S., Sutomo, R., & Nurnaningsih. (2017). Hubungan terapi cairan Ringer Laktat dengan hiponatremia pada sindrom syok dengue. Repository Universitas Gadjah Mada. https://repository.ugm.ac.id

Khan, M. B., Yang, Z. S., Lin, C. Y., Hsu, M. C., Urbina, A. N., Assavalapsakul, W., ... & Wang, S. F. (2023). Dengue overview: An updated systemic review. Journal of Infection and Public Health, 16(10), 1625–1642. https://doi.org/10.1016/j.jiph.2023.08.001

Downloads

Published

2025-07-11

How to Cite

Erwin Ari Pratiwi, Eko Retnowati, & Intan Adevia Rosnarita. (2025). Efektivitas Penggunaan Ringer Laktat Vs Ringer Asetat terhadap Durasi Rawat Inap Pasien Demam Berdarah Dengue. Jurnal Ilmu Kedokteran Dan Kesehatan Indonesia, 5(1), 434–453. https://doi.org/10.55606/jikki.v5i1.7462

Similar Articles

<< < 1 2 3 4 > >> 

You may also start an advanced similarity search for this article.